Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Philadelphia, PA : American Association for Cancer Research, c1991-
    • الموضوع:
    • نبذة مختصرة :
      Background: In the United States, >45,000 adolescent and young adult (AYA) women are diagnosed with cancer annually. Reproductive issues are critically important to AYA cancer survivors, but insufficient information is available to address their concerns. The AYA Horizon Study was initiated to contribute high-quality, contemporary evidence on reproductive outcomes for female cancer survivors in the United States.
      Methods: The study cohort includes women diagnosed with lymphoma, breast, melanoma, thyroid, or gynecologic cancer (the five most common cancers among women ages 15-39 years) at three study sites: the state of North Carolina and the Kaiser Permanente health systems in Northern and Southern California. Detailed information on cancer treatment, fertility procedures, and pregnancy (e.g., miscarriage, live birth) and birth (e.g., birth weight, gestational length) outcomes are leveraged from state cancer registries, health system databases and administrative insurance claims, national data on assisted reproductive technology procedures, vital records, and survey data.
      Results: We identified a cohort of 11,072 female AYA cancer survivors that includes >1,200 African American women, >1,400 Asian women, >1,600 Medicaid enrollees, and >2,500 Hispanic women using existing data sources. Active response to the survey component was low overall ( N = 1,679), and notably lower among minority groups compared with non-Hispanic white women.
      Conclusions: Passive data collection through linkage reduces participant burden and prevents systematic cohort attrition or potential selection biases that can occur with active participation requirements.
      Impact: The AYA Horizon study will inform survivorship planning as fertility and parenthood gain increasing recognition as key aspects of high-quality cancer care.
      (©2021 American Association for Cancer Research.)
    • References:
      Cancer. 2013 Jan 1;119(1):201-14. (PMID: 22744865)
      Obstet Gynecol. 2004 Mar;103(3):551-63. (PMID: 14990421)
      Hum Reprod. 2018 Jul 1;33(7):1281-1290. (PMID: 29912328)
      BMC Cancer. 2013 Jan 23;13:30. (PMID: 23343211)
      Fertil Steril. 2019 Dec;112(6):1022-1033. (PMID: 31843073)
      Cancer Epidemiol. 2020 Feb;64:101652. (PMID: 31811983)
      Oncologist. 2015 Feb;20(2):186-95. (PMID: 25568146)
      Hum Reprod. 2012 Aug;27(8):2413-9. (PMID: 22674206)
      Fertil Steril. 2019 Sep;112(3):562-568. (PMID: 31262522)
      Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):776-82. (PMID: 23596095)
      J Clin Oncol. 2009 Jun 10;27(17):2881-5. (PMID: 19403885)
      N Engl J Med. 2017 Oct 26;377(17):1607-1609. (PMID: 29069561)
      J Cancer Surviv. 2011 Sep;5(3):305-14. (PMID: 21274648)
      PLoS Med. 2006 Sep;3(9):e336. (PMID: 16968117)
      NCHS Data Brief. 2019 Jul;(346):1-8. (PMID: 31442195)
      J Clin Oncol. 2009 Jun 1;27(16):2677-85. (PMID: 19364965)
      Fertil Steril. 2013 Jan;99(1):37-43. (PMID: 23083924)
      Cancer Causes Control. 2016 Nov;27(11):1315-1323. (PMID: 27639398)
      J Clin Oncol. 2018 Jul 20;36(21):2169-2180. (PMID: 29874135)
      J Natl Cancer Inst Monogr. 2005;(35):12-25. (PMID: 16287881)
      J Adolesc Young Adult Oncol. 2016 Sep;5(3):240-7. (PMID: 27111543)
      J Natl Cancer Inst. 2004 Jan 21;96(2):148-52. (PMID: 14734705)
      Hum Reprod. 2004 Feb;19(2):272-7. (PMID: 14747166)
      Semin Oncol. 2013 Apr;40(2):156-67. (PMID: 23540741)
      Lancet Glob Health. 2019 Jan;7(1):e37-e46. (PMID: 30389451)
      Med Care. 2016 Sep;54(9):e55-64. (PMID: 24638121)
      Cancer. 2018 Nov 15;124(22):4401-4407. (PMID: 30403424)
      J Adolesc Young Adult Oncol. 2013 Jun;2(2):59-65. (PMID: 23781402)
      Natl Vital Stat Rep. 2014 Sep 24;63(5):1-6. (PMID: 25252091)
      Eur J Cancer. 2019 Apr;111:126-137. (PMID: 30849686)
      US Statut Large. 1992 Oct 24;106:3146-52. (PMID: 11660823)
      J Cancer Surviv. 2013 Mar;7(1):55-62. (PMID: 23239136)
      Int J Cancer. 2011 Sep 1;129(5):1225-36. (PMID: 21387311)
      CA Cancer J Clin. 2019 Nov;69(6):485-496. (PMID: 31594027)
      Cancer. 2013 May 15;119(10):1892-9. (PMID: 23436251)
      Med Care. 2013 Oct;51(10):e67-73. (PMID: 22531648)
      J Clin Oncol. 2018 Jul 1;36(19):1994-2001. (PMID: 29620997)
      J Adolesc Young Adult Oncol. 2018 Nov 16;:. (PMID: 30452301)
      N C Med J. 2014 Jul-Aug;75(4):265-9. (PMID: 25046092)
      JAMA Oncol. 2017 Aug 01;3(8):1078-1084. (PMID: 28334337)
      JNCI Cancer Spectr. 2019 Apr 09;3(1):pkz008. (PMID: 31360893)
      J Natl Cancer Inst. 2013 Jan 16;105(2):85-94. (PMID: 23197494)
      Lancet Oncol. 2013 Aug;14(9):873-81. (PMID: 23856401)
      Cancer Treat Res. 2010;156:153-70. (PMID: 20811831)
      J Cancer Surviv. 2018 Aug;12(4):592-600. (PMID: 29785559)
      J Cancer Surviv. 2012 Sep;6(3):239-50. (PMID: 22457219)
      Nat Rev Clin Oncol. 2015 Aug;12(8):465-80. (PMID: 26011488)
      J Natl Compr Canc Netw. 2018 Jan;16(1):66-97. (PMID: 29295883)
    • Grant Information:
      P30 CA016086 United States CA NCI NIH HHS; P30 ES010126 United States ES NIEHS NIH HHS; R01 CA204258 United States CA NCI NIH HHS; T32 CA057726 United States CA NCI NIH HHS
    • الموضوع:
      Date Created: 20210223 Date Completed: 20220112 Latest Revision: 20221005
    • الموضوع:
      20240105
    • الرقم المعرف:
      PMC8102328
    • الرقم المعرف:
      10.1158/1055-9965.EPI-20-1315
    • الرقم المعرف:
      33619021